资讯

Contract Pharma4 小时
AGC Biologics Expands Cell Therapy Development Operations to Asia
AGC Biologics will commence cell therapy process development and clinical manufacturing services at AGC Inc.’s Yokohama ...
Porton Advanced and EVA Pharma Sign MOU to Expand CAR T-Cell Therapy Access in The Middle ...
Porton Advanced Solutions, a global leading cell and gene therapy CDMO service provider, and EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the ...
AllAfrica on MSN5 小时
Sickle Cell Day - Patients Battle High Cost of Drugs, Access to Treatment
People living with Sickle Cell Disease (SCD) in Nigeria have lamented that the high cost of medication and poor access to comprehensive care are weighing heavily on them and their families.They also ...
AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market Need
AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1 at AGC Inc.’s ...